Research Article: Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Replication Genes
Introduction:
Acute myeloid leukemia (AML) is a common hematological malignancy that increasingly appears with age, with a median age of years at diagnosis. The standard treatment regimen for AML consists of intensive induction chemotherapy (anthracyclines plus cytarabine) to achieve complete remission (CR), followed by consolidation with high-dose cytarabine or hematopoietic stem cell transplantation (HSCT). Despite the high response rates, most patients with AML eventually relapse and die from the disease. In addition, AML…
Read more